Berlin, Germany : 9 - 12 September 2018
Goodbye Flat Biology brings together researchers who are interested in the techniques and applications of 3D culture at the cancer biology, engineering and drug development interface. The meeting has a reputation for outstanding science, international participation, and excellent opportunities for interaction and networking. Registration places are limited, so don’t miss out!
Cancer progression and resistance to therapy in patients are complex processes, involving distinct cancer cell phenotypes and diverse immune and fibroblastic regulators and extracellular co-conspirators. These interactions are themselves affected by the molecular and mechanical properties of the tumour's microenvironment.
The structure, dynamics and molecular reprogramming of a tumour have proven difficult to model in conventional 2D cell culture. The limitations on the biology that can be modelled in 2D culture constrains the processes that can be studied and the targets that can be identified.
Efforts to bridge this gap have led to a renaissance in the development of 3D culture models, with distinct approaches arising from techniques in cell biology, developmental biology, and engineering.
Faculty, postdocs, and trainees interested in techniques and applications of 3D culture at the insection of cancer biology, engineering, and drug development.
Industry scientists interested in identifying promising platforms for drug discovery and targets for novel therapies.
Andrew Ewald (chair) USA
Peter Friedl NETHERLANDS / USA
Ellen Van Obberghen-Schilling FRANCE
Emmy Verschuren FINLAND
Maria Vinci ITALY
Bursary application deadline:
15 June 2018
Abstract submission deadline:
15 June 2018
31 July 2018
100% of the participants from the last edition would recommend the conference to others.
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.